Psilocybin-assisted psychotherapy for treatment-resistant obsessive–compulsive disorder: protocol for an open-label pilot study

Benzer Materyaller

• Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive–compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial
  Yazar:: Terence H. W. Ching, ve diğerleri
  Baskı/Yayın Bilgisi: (2023-04-01)
• Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study
  Yazar:: Luca Pellegrini, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-10-01)
• Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysis
  Yazar:: T. H. W. Ching, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-12-01)
• Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?
  Yazar:: N. Descalço, ve diğerleri
  Baskı/Yayın Bilgisi: (2021-04-01)
• Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings
  Yazar:: Terence H. W. Ching, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-01-01)